ATS Breathe Easy

ATS 2026 is quickly approaching! This iteration of the international conference will feature amazing panels, speakers, and forums. On this episode of the ATS Breathe Easy, host Ugo Ezema, MD, Tulane University, gives us a preview by highlighting the keynotes on Sunday and Monday. Katherine Hisert, MD, PhD, National Jewish Health, discusses the Sunday keynote: "Vaccines - Past, Present and Future" by Demetre Daskalakis, MD, MPH. Joshua Fessel, MD, PhD, ATSF, talks about the Monday keynote he will be moderating: "The Supreme Court, the Administrative State, and You" with Stephen Vladeck, JD. There’s still time to register for ATS 2026! https://registration.experientevent.com/ShowATS261/Flow/ATT?atslogin=1&marketingcode=YOUTUBE

Artificial intelligence is at the center of dozens of new tools and technological advances, but how should clinicians and researchers integrate them into their practice and research? The ATS AI Taskforce was formed to help answer this question, explore the latest innovations in the space, and how it fits into the needs of ATS members. Shirin Shafazand, MD, MS, FAASM, ATSF, University of Miami, and past-president of the ATS David Gozal, MD, MBA, Marshall University, join host Eddie Qian, MD, Vanderbilt University, to discuss this new taskforce, talk about AI programming at ATS 2026, and how AI is helping to shape the future of medicine.

The U.S. Environmental Protection Agency (EPA) changed the dollar value of a statistical life in January 2026, essentially dropping it to zero. What does that mean for the average American? As Anthony Gerber, MD, PhD, University of Kentucky, explains to Air Health Our Health host Erika Moseson, MD, MA, this means the agency will no longer account for the healthcare costs of air pollution and lost lives when determining how account how clean air policies and other key legislation affect communities. In this conclusion of a two-part series on the EPA’s dollar value of a statistical life, Dr. Gerber explains what this change means and why is it significant.

How can peers help those in their field entering mid-career? Through the sharing of their successes and struggles. This was the solution Joshua Lee Denson, MD, MS, Tulane University, and colleagues came up with when asked for event ideas for the ATS International Conference. The ATS Storytelling Series has been a huge success, giving mid-career professionals a space to highlight wins, discuss issues, and connect with a community of professionals looking to advance and expand. Dr. Denson and host Amy Attaway, MD, Cleveland Clinic, talk about how this series was developed, how it has helped others in the past, and what to look forward to at ATS 2026. Be sure to register for ATS 2026: https://registration.experientevent.com/ShowATS261/Flow/ATT?atslogin=1&marketingcode=YOUTUBE

This is the second episode of our discussions on the experiences and challenges of transitioning into being a mid-career professional. For many, mid-career brings a wave of financial and personal pressure, leaving them working out how to handle new milestones and systems while managing their careers. Last Zebra Podcast creator Ugo Ezema, MD, of Tulane University hosts this episode. He speaks with fellow Tulane University colleague Joshua Lee Denson, MD, MS, and Kristina Montemayor, MD, MHS, Johns Hopkins University, about financial education, negotiation skills, retirement planning, leadership boundaries, and more.Be sure to register for ATS 2026 for some of the great mid-career programs, including the ATS Storytelling series, the Mid-Career Roadmap and Toolkit, Scientific Symposium: Breathing New Life Into Your Career.

Biologics have changed how patients with asthma are able to handle their symptoms and prevent them from getting worse. Host Amy Attaway, MD, Cleveland Clinic, talks with Monica Kraft, MD, Icahn School of Medicine at Mount Sinai, and De De Gardner, DrPh, Allergy and Asthma Network and member of PAR about depemokimab, the newest biologic for those with severe asthma. Learn how this novel treatment is used once every six months to improve patient outcomes, as well as the research behind this biologic and the future of asthma treatment. Read Dr. Kraft's paper on depemokimab: https://journal.chestnet.org/article/S0012-3692(25)00855-4/pdf Editor's note: During this episode, Dr. Kraft mistakenly said that depemokimab was approved for treating nasal polyps. Please note that depemokimab is not approved for treating this condition.

Scientific research grants were abruptly terminated for hundreds of researchers including those in the ATS community in 2025. Many of these resulted in research that had already been done and was in final stages being discarded. Important studies done with community collaboration are at risk. Neeta Thakur, MD, of the University of California San Francisco, was one such researcher. Her EPA grant to study the effects of wildfire smoke on vulnerable communities was abruptly terminated. Dr. Thakur discusses her experience receiving the cuts, collaborating with other researchers on a lawsuit to restore the funding and finish the research, and how these cuts will affect the future of health and patient outcomes with Air Health Our Health host Erika Moseson, MD, MA. For more on funding cuts, listen to prior ATS Breathe Easy podcast episodes: - ATS Breathe Easy - The Real Cost of Federal Budget Cuts: https://www.youtube.com/watch?v=49g5RBSqMkE - ATS Breathe Easy - The Human Cost of the NIH Cuts: https://www.youtube.com/watch?v=9dIlg_L7qqI

We all know that sleep is important, but how much can eight hours really do for us? Turns out, a good night’s rest does more than restore our energy; restful sleep helps regulate weight, blood sugar, and even blood pressure. Ding Zou, MD, PhD, and Mio Kobayashi Frisk, MD, of the University of Gothenburg, studied how conditions like sleep apnea and insomnia affect hypertension, with those getting less sleep having higher instances of elevated blood pressure levels. Host Patti Tripathi discusses their study, what solutions exist for better sleep, and what future studies may look like. Read the paper: https://www.atsjournals.org/doi/abs/10.1513/AnnalsATS.202501-080OC

Regulation is key to keeping our air clean, which in turn keeps us healthy. But the Trump Administration has been cutting funding and attempting to slash important clean air rules that jeopardize the planet and our health. What do these policy changes mean, and how can organizations help fight back? Part of the answer is going to federal courts. Nicholas Nassikas, MD, Harvard Medical School, and Andrew Mergen, Harvard Law School, discuss the legal actions the ATS has taken to oppose rollbacks of essential Clean Air Act rules with host Gary Ewart, MHS, chief of advocacy and government relations for the American Thoracic Society.

As 2025 comes to a close, the ATS Breathe Easy podcast is highlighting one of our most important episodes of the year on the importance of environmental justice, both for the quality of our air and for the quality of life of future generations. Erika Moseson, MD, of the Air Health Our Heath podcast hosts this week's episode with guest Daniel Croft, MD, MPH, ATSF. Dr. Croft is associate professor in the Division of Pulmonary and Critical Care Medicine and the Department of Environmental Medicine at the University of Rochester Medical Center. On this episode we share insights from the Climate Change and Respiratory Health: Opportunities to Contribute to Environmental Justice: An Official American Thoracic Society Workshop Report: https://pubmed.ncbi.nlm.nih.gov/40311081/ For additional discussion on environmental health, please also view our recent Breathe Easy episode “EPA Rollbacks Spell Grave Impacts on Public Health” for an up-to-date discussion of current national changes related to health care, environmental health and environmental justice: https://www.youtube.com/watch?v=51ZzGPj8UF4 For more on what you can do in your community, listen to the Air Health Our Health episode "Bypass Toxic Politics" with Dr Anthony Gerber of the American Thoracic Society Environmental Health Policy Committee: https://creators.spotify.com/pod/profile/airhealthourhealth/episodes/Bypass-Toxic-Politics--Dr-Gerber-on-Local-and-State-Action-for-Healthy-Air-and-Communities-e2tug4n/a-abobsm0

Lung cancer is commonly associated with smoking. However, among people diagnosed with lung cancer, the proportion who have never smoked has been increasing, and there are many reasons why a person who has never smoked may develop this disease. Lori Sakoda, PhD, MPH, ATSF, a research scientist and epidemiologist at Kaiser Permanente Northern California, explains what factors may come into play, what the ongoing research shows, and what knowledge gaps exist on this topic. Patti Tripathi hosts.

This Giving Tuesday, we have a special episode of the ATS Breathe Easy podcast. Wildfires are a destructive phenomenon that decimates communities, infrastructure, and wildlife. But wildfires and wildfire smoke are also severely damaging to human health, especially for those who have lung disease. Stacie Reveles, of the Cystic Fibrosis Research Institute, talks about her struggles living in wildfire country with a child who has cystic fibrosis. She discusses everything from dealing with medications and evacuations, the mental toll, and the importance of continued research into these illnesses. Air Health Our Health podcast creator Erika Moseson, MD, MA, of Legacy Health in Oregon hosts. Donate to the ATS Research Program today to help families like Stacie's: https://aeugmntn.donorsupport.co/page/Stacie The ATS Wildfire Disaster Guidance sheet: https://www.thoracic.org/patients/patient-resources/resources/wildfires.pdf Listen to the Our Health in Wildfire Season episode of Air Health Our Health for how to prepare your home and community: https://creators.spotify.com/pod/profile/airhealthourhealth/episodes/Our-Health-in-Wildfire-Season-e162en9/a-a2ata11

Exercise is key for managing symptoms for COPD patients. On World COPD Day, host Amy Attaway, MD, Cleveland Clinic, talks to Rachel Evans, MD, University of Leicester, and Russell Winwood, a patient advocate known as the "COPD Athlete", about how exercise can improve patient outcomes. They also discuss the annual Big Baton Pass, an international COPD awareness event, the importance for pulmonary rehabilitation, and the community built around COPD advocacy and support for patients. Learn more about the COPD Baton Pass: https://copdbatonpass.org/